2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Glomerulosclerosis, Focal Segmental: new trials by email Literature Review of Glomerulosclerosis, Focal Segmental trials Research Report on Glomerulosclerosis, Focal Segmental
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects Dapagliflozin - Focal Segmental Glomerulosclerosis | Phase 4 | Completed | University Health Network, Toronto | 10 | 2015-09-01 | 2018-01-16 |
| Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) ACTHAR gel - Treatment Resistant Nephrotic Syndrome | Phase 4 | Completed | Columbia University | 15 | 2009-12-01 | 2014-04-24 |
Proteinuria (2) · Glomerulonephritis, IGA (1) · Glomerulonephritis, Membranous (1) · Nephrosis, Lipoid (1) · Nephrotic Syndrome (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glomerulonephritis (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urination Disorders (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2) · Autoimmune Diseases (1) · Chronic Disease (1) · Disease Attributes (1)
dapagliflozin (1)
Columbia University (1) · University Health Network, Toronto (1)
Canada (1) · United States (1)